SCHEMBL572714

SCHEMBL572714

CCCCCN(CCCCC)c1cc(C(=O)OC)cc(S(=O)(=O)/N=C/N(C)C)c1Oc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ SLC12A2 P55011 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ AQP1 P29972 1/20 0.34
▸ PTGS2 P35354 3/20 0.34
▸ LPAR1 Q92633 1/20 0.33
▸ LPAR5 Q9H1C0 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ S1PR3 Q99500 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572715 1.00 ALDH1A1 (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL10224224 1.00 ALDH1A1 (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL572943 0.99 LMNA (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL572944 0.99 LMNA (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL10224228 0.99 LMNA (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL574196 0.97 ALDH1A1 (0.40) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL574197 0.97 ALDH1A1 (0.40) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL573814 0.94 LMNA (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL573815 0.94 LMNA (0.39) ALDH1A1KDM4EUSP2CA2LMNA
SCHEMBL574057 0.92 LPAR1 (0.39) ALDH1A1KDM4EUSP2CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback